Slaughter and May is advising Hikma Pharmaceuticals PLC in relation to its acquisition of Medlac Pharma Italy, Co. Ltd.
Slaughter and May is advising Hikma Pharmaceuticals PLC (Hikma) in relation to its acquisition of Medlac Pharma Italy, Co. Ltd. (Medlac), an injectable manufacturing company in Vietnam. The acquisition includes a high-quality injectable facility, adjacent vacant land, Medlac’s product portfolio of 23 injectable products, its pipeline and all employees.
The acquisition was announced on 7 November 2018.